153 related articles for article (PubMed ID: 21039317)
1. CT imaging with iopromide liposomes in a rabbit model.
Krause W; Schönborn A; Rupp K
J Liposome Res; 2011 Sep; 21(3):229-36. PubMed ID: 21039317
[TBL] [Abstract][Full Text] [Related]
2. Characterization of continuously extruded iopromide-carrying liposomes for computed tomography blood-pool imaging.
Leike JU; Sachse A; Rupp K
Invest Radiol; 2001 Jun; 36(6):303-8. PubMed ID: 11410749
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of the iodine-free computed tomography liver contrast agent, Dy-EOB-DTPA, in comparison with a conventional iodinated agent in normal and in tumor-bearing rabbits.
Krause W; Handreke K; Schuhmann-Giampieri G; Rupp K
Invest Radiol; 2002 May; 37(5):241-7. PubMed ID: 11979149
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of lyophilized iopromide-carrying liposomes for liver tumor detection.
Sachse A; Leike JU; Rössling GL; Wagner SE; Krause W
Invest Radiol; 1993 Sep; 28(9):838-44. PubMed ID: 8225891
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution and computed tomography blood-pool imaging properties of polyethylene glycol-coated iopromide-carrying liposomes.
Sachse A; Leike JU; Schneider T; Wagner SE; Rössling GL; Krause W; Brandl M
Invest Radiol; 1997 Jan; 32(1):44-50. PubMed ID: 9007647
[TBL] [Abstract][Full Text] [Related]
6. Characterization of iopromide liposomes.
Krause W; Leike J; Sachse A; Schuhmann-Giampieri G
Invest Radiol; 1993 Nov; 28(11):1028-32. PubMed ID: 8276573
[TBL] [Abstract][Full Text] [Related]
7. CT blood pool enhancement in primates with lopromide-carrying liposomes containing soy phosphatidyl glycerol.
Schmiedl UP; Krause W; Leike J; Sachse A
Acad Radiol; 1999 Mar; 6(3):164-9. PubMed ID: 10898035
[TBL] [Abstract][Full Text] [Related]
8. Detection of focal liver lesions at biphasic spiral CT: randomized double-blind study of the effect of iodine concentration in contrast materials.
Hänninen EL; Vogl TJ; Felfe R; Pegios W; Balzer J; Clauss W; Felix R
Radiology; 2000 Aug; 216(2):403-9. PubMed ID: 10924561
[TBL] [Abstract][Full Text] [Related]
9. Iopromide-carrying liposomes as a contrast agent for the liver.
Krause W; Leike J; Schuhmann-Giampieri G; Sachse A; Schmiedl U; Strunk H
Acad Radiol; 1996 Aug; 3 Suppl 2():S235-7. PubMed ID: 8796571
[No Abstract] [Full Text] [Related]
10. Blood pool and liver enhancement in CT with liposomal lodixanol: comparison with lohexol.
Desser TS; Rubin DL; Muller H; McIntire GL; Bacon ER; Toner JL
Acad Radiol; 1999 Mar; 6(3):176-83. PubMed ID: 10898037
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of iopromide liposomes in rabbits.
Schuhmann-Giampieri G; Leike J; Sachse A; Krause W
Pharm Res; 1995 Jul; 12(7):1065-71. PubMed ID: 7494804
[TBL] [Abstract][Full Text] [Related]
12. Preclinical characterization of iopromide-carrying liposomes.
Krause W; Sachse A; Wagner S; Kollenkirchen U; Rössling G
Invest Radiol; 1991 Nov; 26 Suppl 1():S172-4; discussion S175-6. PubMed ID: 1808120
[No Abstract] [Full Text] [Related]
13. Dynamic contrast-enhanced computed tomography to assess antitumor treatment effects: comparison of two contrast agents with different pharmacokinetics.
Jost G; Pietsch H; Grenacher L
Invest Radiol; 2013 Oct; 48(10):715-21. PubMed ID: 23666093
[TBL] [Abstract][Full Text] [Related]
14. Contrast timing in computed tomography: effect of different contrast media concentrations on bolus geometry.
Mahnken AH; Jost G; Seidensticker P; Kuhl C; Pietsch H
Eur J Radiol; 2012 Apr; 81(4):e629-32. PubMed ID: 22297184
[TBL] [Abstract][Full Text] [Related]
15. Body surface area adapted iopromide 300 mg/ml versus 370 mg/ml contrast medium injection protocol: influence on quantitative and clinical assessment in combined PET/CT.
Verburg FA; Apitzsch J; Lensing C; Kuhl CK; Pietsch H; Mottaghy FM; Behrendt FF
Eur J Radiol; 2013 Dec; 82(12):2348-52. PubMed ID: 24113432
[TBL] [Abstract][Full Text] [Related]
16. Liver contrast enhancement in primates using iopromide liposomes.
Schmiedl UP; Krause W; Leike J; Nelson JA; Schuhmann-Giampieri G
Acad Radiol; 1995 Nov; 2(11):967-72. PubMed ID: 9419668
[TBL] [Abstract][Full Text] [Related]
17. Assessing the effectiveness of X-ray contrast media for abdominal computed tomographic examinations: comparison of four low-osmolality agents.
Martí-Bonmatí L; Ronchera-Oms CL; Espinós MA; Jordán Y; Lucas A
J Clin Pharm Ther; 1995 Apr; 20(2):75-81. PubMed ID: 7650078
[TBL] [Abstract][Full Text] [Related]
18. Significant perturbation in renal functional magnetic resonance imaging parameters and contrast retention for iodixanol compared with iopromide: an experimental study using blood-oxygen-level-dependent/diffusion-weighted magnetic resonance imaging and computed tomography in rats.
Wang YC; Tang A; Chang D; Zhang SJ; Ju S
Invest Radiol; 2014 Nov; 49(11):699-706. PubMed ID: 24879299
[TBL] [Abstract][Full Text] [Related]
19. CT of the abdomen: degree and quality of enhancement obtained with two concentrations of the same iodinated contrast medium with fixed iodine delivery rate and total iodine load.
Paparo F; Garello I; Bacigalupo L; Marziano A; Galletto Pregliasco A; Rollandi L; Puppo C; Mattioli F; Puntoni M; Rollandi GA
Eur J Radiol; 2014 Nov; 83(11):1995-2000. PubMed ID: 25174776
[TBL] [Abstract][Full Text] [Related]
20. Intraindividual comparison of contrast media concentrations for combined abdominal and thoracic MDCT.
Behrendt FF; Mahnken AH; Stanzel S; Seidensticker P; Jost E; Günther RW; Mühlenbruch G
AJR Am J Roentgenol; 2008 Jul; 191(1):145-50. PubMed ID: 18562738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
